CREDIT SUISSE AG/ - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,341,151
+15.1%
42,577
+2.7%
0.00%0.0%
Q1 2023$3,770,998
+153.6%
41,476
+6.0%
0.00%
+100.0%
Q4 2022$1,487,005
+99.1%
39,142
+31.8%
0.00%
+100.0%
Q3 2022$747,000
-16.8%
29,690
+0.5%
0.00%0.0%
Q2 2022$898,000
-2.5%
29,532
+5.0%
0.00%0.0%
Q1 2022$921,000
+29.5%
28,125
+4.3%
0.00%
Q4 2021$711,000
-74.5%
26,960
-2.8%
0.00%
-100.0%
Q3 2021$2,789,000
-23.3%
27,725
+7.9%
0.00%0.0%
Q2 2021$3,636,000
+46.0%
25,699
+2.8%
0.00%
+100.0%
Q1 2021$2,491,000
-2.6%
24,994
+20.9%
0.00%0.0%
Q4 2020$2,557,000
+33.8%
20,679
+5.4%
0.00%0.0%
Q3 2020$1,911,000
-36.4%
19,623
+1.8%
0.00%
-50.0%
Q2 2020$3,006,000
-28.2%
19,268
-33.6%
0.00%
-50.0%
Q1 2020$4,187,000
-51.9%
29,009
-31.9%
0.00%
-33.3%
Q4 2019$8,711,000
+420.7%
42,612
+104.5%
0.01%
+500.0%
Q3 2019$1,673,000
+21.5%
20,836
+42.7%
0.00%0.0%
Q2 2019$1,377,000
-43.5%
14,603
-48.8%
0.00%
-50.0%
Q1 2019$2,439,000
+88.0%
28,525
+23.4%
0.00%
+100.0%
Q4 2018$1,297,000
-26.4%
23,115
+7.2%
0.00%
-50.0%
Q3 2018$1,763,000
+118.7%
21,566
-6.4%
0.00%
+100.0%
Q2 2018$806,000
+114.4%
23,052
+25.7%
0.00%
Q1 2018$376,000
-25.1%
18,344
+3.4%
0.00%
Q4 2017$502,000
+78.0%
17,738
+96.0%
0.00%
Q3 2017$282,0009,0520.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders